Cassady Schiller Wealth Management, LLC Intellia Therapeutics, Inc. Transaction History
Cassady Schiller Wealth Management, LLC
- $268 Million
- Q4 2024
A detailed history of Cassady Schiller Wealth Management, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 62 shares of NTLA stock, worth $593. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62Holding current value
$593% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
326Shares Held
94.1MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$120 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$97.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$91.9 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$49.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$47.4 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $728M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...